COVID-19 Human IgM IgG ELISAキット(Nucleocapsid Protein)

​SDS

測定方法:　　　間接 ELISA 法

測定波長:　　　450 nm

測定試料:　　　血清

交差性:　　　　Human

保管温度:　　　4°C保管

品質保証期限:   本品の有効期限は製造後 12 カ月です。

プレートへの固相化抗原:　SARS-CoV-2 ヌクレオカプシドタンパク（全長, 大腸菌発現系）

​

​

キット内容

1. SARS-CoV-2 ヌクレオカプシドタンパク固相化プレート

2. HRP 標識抗ヒト IgM 抗体

3. HRP 標識抗ヒト IgG 抗体

4. 洗浄液(10× PBST)

5. ウシ血清アルブミン（Diluent 用）

6. Diluent 用バッファー (10×)

7. R-1:発色基質 (TMB)

8. R-2:反応停止液 (1 mol/L 塩酸)

9. マイクロプレートシール

×2

20 μL×1

20 μL×1

100 mL×1

×1

50 mL×1

22 mL×1

22 mL×1

×2

測定原理

1. 固相化プレート上の リコンビナント SARS-CoV-2 ヌクレオカプシドタンパク と、これを認識する試料中の抗体(以後、抗ヌクレオカプシドタンパク抗体と略称)を反応させる。

2. 反応後、試料を洗浄操作により除去する。

3. 固相化プレート上の 抗ヌクレオカプシドタンパク抗体と、HRP (Horseradish peroxidase) 標識抗ヒト IgM / IgG 抗体を反応させる。

4. 余剰の HRP 標識抗ヒト IgM / IgG 抗体を洗浄操作により除去する。発色基質を加え、吸光度を測定する。

　本キットは、COVID-19 の原因ウイルスである、SARS-CoV-2 のヌクレオカプシドタンパクを認識するヒトIgM 抗体とヒト IgG 抗体を検出するための研究用 ELISA キットです。 

　ウイルスの検出には、大きく分けて二種類のアプローチ法があり、PCR 法などのウイルス自体を検出する方法と、感染時に発現する免疫反応(IgG, IgM, IgA)を検出する方法があります。一般的 な感染症において、IgM は感染初期に生成される抗体で、症状の緩和とともに消失します。IgG は IgM に遅れて産生が始まり、治癒後も数カ月にわたって産生され続けます。これにより次に感染した際の症状が軽くなったり、発症を防いだりすることが知られています。

​

​

本キット使用文献

• Kazuo Imai et al.
  Antibody response patterns in COVID-19 patients with different levels of disease severity-Japan

      J Med Virol. 2021 Feb 23. PubMed PMID: 33620098.

• Issaka Sagara et al.
  SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali

      medRxiv. 2021 Mar. PubMed PMID: 33758883

• Tomoya Tsuchida et al.
  Back to normal; serological testing for COVID-19 diagnosis unveils missed infections

      J Med Virol. 2021 Mar. PubMed PMID: 33739483

• Daniëlle A. T. Hanssen et al.
  Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples

      Eur J Clin Microbiol Infect Dis. 2021 Mar. PubMed PMID: 33733395

• Louise C Rowntree et al.
  Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features​

      lin Transl Immunology. 2021 Feb. PubMed PMID: 33680466

• Israel Zyskind et al.
  SARS-CoV-2 Seroprevalence and Symptom Onset in Culturally Linked Orthodox Jewish Communities Across Multiple Regions in the United States​

      JAMA Netw Open. 2021 Mar. PubMed PMID: 33688968

• Huaqing Shu et al.
  Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak

      Virol Sin. 2020 Dec. PubMed PMID: 32720214

• Petra Emmerich et al.
  Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin

      Trop Med Int Health. 2021 Mar. PubMed PMID: 33666297

• Helena Cerutti et al.
  Large scale production and characterization of SARS-CoV-2 whole antigen for serological test development​

      J Clin Lab Anal. 2021 Feb. PubMed PMID: 33608968

• Xiao-Lin Jiang et al.
  Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection

      Nat Commun. 2021 Feb. PubMed PMID: 33563974

• Andrea Tešija Kuna et al.
  Comparison of diagnostic accuracy for eight SARS-CoV-2 serological assays

      Biochem Med (Zagreb). 2021 Feb. PubMed PMID: 33594297​

• Hadeel T Al-Jighefee et al.
  Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kit

      Pathogens. 2021 Feb. PubMed PMID: 33546341

• Hadi M. Yassine et al.
  Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies Int J Infect Dis. 2021 Jan. PubMed PMID: 33127504

      Int J Infect Dis. 2021 Jan. PubMed PMID: 33127504​

• Abdullah Algaissi et al.
  SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients

      Sci Rep. 2020 Oct. PubMed PMID: 33024213

• Bijon Kumar Sil et al.
  Development and performance evaluation of a rapid in-house ELISA for retrospective serosurveillance of SARS-CoV-2

      PLoS One. 2021 Feb. PubMed PMID: 33529223

• Jan Van Elslande et al.
  Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs

      Clin Microbiol Infect. 2020 Nov. PubMed PMID: 32745595

• Dachuan Lin et al.
  Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak

      Eur J Clin Microbiol Infect Dis. 2020 Jul 17. PubMed PMID: 32681308

• Silvano Wendel et al.
  Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program

      Transfusion. 2020 Dec. PubMed PMID: 32935877

• Larry L. Luchsinger et al.
  Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients​

      J Clin Microbiol. 2020 Dec. PubMed PMID: 32917729

• Mario Plebani et al.
  Performance of the COVID19SEROSpeed IgM/IgG Rapid Test, an Immunochromatographic Assay for the Diagnosis of SARS-CoV-2 Infection: a Multicenter European Study​

      J Clin Microbiol. 2021 Jan. PubMed PMID: 33218990

• Melanie A MacMullan et al.
  Detection of SARS-CoV-2 Antibodies in Oral Fluid Obtained Using a Rapid Collection Device​

      J Clin Microbiol. 2021 Jan. PubMed PMID: 33234589

• Melanie A. MacMullan et al.
  ELISA detection of SARS-CoV-2 antibodies in saliva​

      Sci Rep. 2020 Nov. PubMed PMID: 33257702

• Mª Isabel Galá et al.
  Hospital-Wide SARS-CoV-2 seroprevalence in health care workers in a Spanish teaching hospital​

      Enferm Infecc Microbiol Clin. 2020 Dec. PubMed PMID: 33485676

• N. Davidson et al.
  Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort

      Pathology. 2020 Dec. PubMed PMID: 33070955

• Ivana Lapić et al.
  The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital

      Croat Med J. 2020 Dec 31. PubMed PMID: 33410294​

• Anja Dörschug et al.
  Comparison of Five Serological Assays for the Detection of SARS-CoV-2 Antibodies

      Diagnostics (Basel). 2021 Jan 6. PubMed PMID: 33418886

• Ling L et al.
  Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients

      J Transl Med. 2021 Jan 7. PubMed PMID: 33413461

• Sanne Jespersen et al.
  SARS-CoV-2 seroprevalence survey among 17,971 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region

      Clin Infect Dis. 2020 Oct 3. PubMed PMID: 33011792

• Saahir Khan et al.
  Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray

      Version 1. bioRxiv. 2020 Mar. PubMed PMID: 32511324

• Julien Marlet et al.
  Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care setting

      J Clin Virol. 2020 Nov. PubMed PMID: 32927357

• Kasper Iversen et al.
  Risk of COVID-19 in health-care workers in Denmark: an observational cohort study

      Lancet Infect Dis. 2020 Dec. PubMed PMID: 32758438

• Christina A Rostad et al.
  Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C)

      Pediatrics. 2020 Dec. PubMed PMID: 32879033

• Kening Li et al.
  Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19

      Nat Commun. 2020 Nov 27. PubMed PMID: 33247152

• Victoria Indenbaum et al.
  Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis

      PLoS One. 2020 Nov 23. PubMed PMID: 33227020

• Baweleta Isho et al.
  Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients

      Sci Immunol. 2020 Oct 8. PubMed PMID: 33033173​

• Anges Yadouleton et al.
  Limited Specificity of Serologic Tests for SARS-CoV-2 Antibody Detection, Benin

      Emerg Infect Dis. 2020 Dec 1. PubMed PMID: 33261717

• Maria Carmen Viñuela et al.
  SARS-CoV-2 screening of asymptomatic women admitted for delivery must be performed with a combination of microbiological techniques: an observational study

      Rev Esp Quimioter. 2020 Sep 18. PubMed PMID: 32945157

• Martin Risch et al.
  Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation

      Biomed Res Int. 2020. PubMed PMID: 33224987

• Ainhoa Gutiérrez-Cobos et al.
  Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies

      Eur J Clin Microbiol Infect Dis. 2020 Nov 24. PubMed PMID: 33236268

• Adrian M Shields et al.
  Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response

      medRxiv. Preprint. 2020 Nov 16. PubMed PMID: 33236029

• Constant Gillot et al.
  An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens

      J Clin Med. 2020 Nov 21. PubMed PMID: 33233405

• Shamez N Ladhani et al.
  High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England

      EClinicalMedicine. 2020 Nov 6. PubMed PMID: 33173854

• Pingping Zhang et al.
  Development and evaluation of a serological test for diagnosis of COVID-19 with selected recombinant spike proteins

      Eur J Clin Microbiol Infect Dis. 2020 Nov 12. PubMed PMID: 33184753

• Melkon G DomBourian et al.
  Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays

      J Immunol Methods. 2020 Nov. PubMed PMID: 32828791

• Ling Li et al.
  Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation

      Transfusion. 2020 Aug. PubMed PMID: 32627216

• Guillaume Beaudoin-Bussières et al.
  Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals

      mBio. 2020 Oct 16. PubMed PMID: 33067385

• Phuong Nguyen-Contant et al.
  S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit

       mBio. 2020 Sep 25. PubMed PMID: 32978311

• James R. Byrnes et al.
  Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding

       mSphere. 2020 Sep 16. PubMed PMID: 32938700

• Tyler J Ripperger et al.
  Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity

       Immunity. 2020 Oct 14. PubMed PMID: 33129373

• Pedro Martínez-Fleta et al.
  SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals

       J Immunol. 2020 Nov 4. PubMed PMID: 33148714

• Eshan U Patel et al.
  Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers

       J Clin Microbiol. 2020 Nov 2. PubMed PMID: 33139419

• Zahra Rikhtegaran Tehrani et al.
  Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays

       PLoS One. 2020 Nov 2. PubMed PMID: 33137138

• Bernd Jahrsdörfer et al.
  Independent side-by-side validation and comparison of four serological platforms for SARS-CoV-2 antibody testing

       J Infect Dis. 2020 Oct 16. PubMed PMID: 33064789​

• Xiaohui Wang et al.
  Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein

       mBio . 2020 Oct 20. PubMed PMID: 33082264

• Zhaoqing Lyu et al.
  Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan

       Diseases. 2020 Sep 23. PubMed PMID: 32977485

• Gláucia Cota et al.
  Diagnostic performance of commercially available COVID-19 serology tests in Brazil

       Int J Infect Dis. 2020 Oct 9. PubMed PMID: 33039612

• Álvaro A Faccini-Martínez et al.
  Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia

       Int J Infect Dis. 2020 Sep 28. PubMed PMID: 33002616

• Tao Li et al.
  Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection

       Front Cell Infect Microbiol. 2020 Sep 4. PubMed PMID: 33014893

• Nguyen N Nguyen et al.
  Correlation of ELISA method with three other automated serological tests for the detection of anti-SARS-CoV-2 antibodies

       PLoS One. 2020 Oct 6. PubMed PMID: 33022019

• Elitza S Theel et al.
  Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2

       J Clin Microbiol. 2020 Jul 23. PubMed PMID: 32513859

• Pauline H Herroelen et al.
  Humoral Immune Response to SARS-CoV-2

       Am J Clin Pathol. 2020 Aug 18. PubMed PMID: 32808976

• Anna E Merrill et al.
  Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays

       J Appl Lab Med. 2020 Jul 27. PubMed PMID: 32717056

• Marzia Nuccetelli et al.
  Combined anti-SARS-CoV-2 IgA, IgG, and IgM Detection as a Better Strategy to Prevent Second Infection Spreading Waves

       Immunol Invest. 2020 Sep 18. PubMed PMID: 32945214

• Suzanne Pickering et al.
  Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings

      PLoS Pathog . 2020 Sep 24. PubMed PMID: 32970782

• Zeno Bisoffi et al.
  Sensitivity, Specificity and Predictive Values of Molecular and Serological Tests for COVID-19: A Longitudinal Study in Emergency Room

      Diagnostics (Basel). 2020 Sep 3. PubMed PMID: 32899333

• Eshan Patel et al.
  Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers

      medRxiv . 2020 Sep 2. PubMed PMID: 32908987

• Georg M. N. Behrens et al.
  Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals

      Infect Dis Ther. 2020 Sep 4. PubMed PMID: 32886335

• Niko Kohmer et al.
  Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays

      J Clin Virol. 2020 Aug. PubMed PMID: 32505777

• Hui-Xia Gao et al.
  Detection of serum immunoglobulin M and immunoglobulin G antibodies in 2019 novel coronavirus infected patients from different stages

      Chin Med J (Engl). 2020 Jun 20. PubMed PMID: 32221133

• Sonny Elizaldi et al.
  SARS-CoV-2 infection induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques

      Res Sq. 2020 Aug 14. PubMed PMID: 32818217

• Jeffrey D Whitman et al.
  Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

      Nat Biotechnol. 2020 Aug 27. PubMed PMID: 32855547

• Antonio Cuadrado-Lavín et al.
  Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial

      Trials. 2020 Jun 3. PubMed PMID: 32493494

• Marie Tré‐Hardy et al.
  Analytical and clinical validation of an ELISA for specific SARS‐CoV‐2 IgG, IgA, and IgM antibodies

      EJ Med Virol. 2020 Jul 27. PubMed PMID: 32667733

• Baoqing Sun et al.
  Kinetics of SARS-CoV-2 Specific IgM and IgG Responses in COVID-19 Patients

      Emerg Microbes Infect. 2020 Dec. PubMed PMID: 32357808

• Kathleen M McAndrews et al.
  Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications on COVID-19 immunity

      JCI Insight. 2020 Aug 14. PubMed PMID: 32796155

• Zahra Rikhtegaran Tehrani et al.
  Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays

      medRxiv. 2020 Aug 7. PubMed PMID: 32793933

• Jitendra Prasad Mathuria et al.
  Laboratory diagnosis of SARS-CoV-2 - A review of current methods

      J Infect Public Health. 2020 Jul. PubMed PMID: 32534946

• Alexander Krüttgen et al.
  Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG

      J Clin Virol. 2020 Jul. PubMed PMID: 32416599

• Mayara Lisboa Bastos et al.
  Diagnostic Accuracy of Serological Tests for covid-19: Systematic Review and Meta-Analysis

      BMJ. 2020 Jul. PubMed PMID: 32611558

• Lei Liu et al.
  A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients

      Microbes Infect. 2020 May-June. PubMed PMID: 32425648​

• Patrick Sean Sullivan et al.
  Detection of SARS-CoV-2 RNA and Antibodies in Diverse Samples: Protocol to Validate the Sufficiency of Provider-Observed, Home-Collected Blood, Saliva, and Oropharyngeal Samples

      JMIR Public Health Surveill. 2020 Apr-Jun. PubMed PMID: 32310815

• Daniel Shyu et al.
  Laboratory Tests for COVID-19: A Review of Peer-Reviewed Publications and Implications for Clinical UIse

      Mo Med. 2020 May-Jun. PubMed PMID: 32636542

• Jonathan J Deeks et al.

       Antibody tests for identification of current and past infection with SARS-CoV-2

       Cochrane Database Syst Rev. 2020 Jun 25. PubMed PMID: 32584464

• Andrea P Espejo et al.

       Review of Current Advances in Serologic Testing for COVID-19

       Am J Clin Pathol. 2020 Jun 25. PubMed PMID: 32583852

•   Ahidjo Ayouba et al.

       Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human

       coronaviruses SARS-CoV and MERS-CoV

　　J Clin Virol. 2020 Jun 22. PubMed PMID: 32623350

• Antonio Vittorino Gaddi et al
  The Strategic Alliance between Clinical and Molecular Science in the War against SARS-CoV-2, with the Rapid-Diagnostics Test as an Indispensable Weapon for Front Line Doctor

      Int J Mol Sci. 2020 Jun. PubMed PMID: 32580529

• Feng-Cai Zhu et al.
  Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

      Lancet. 2020 13-19 June. PubMed PMID: 32450106

• Wan Ni Chia et al.
  Serological Differentiation Between COVID-19 and SARS Infections

      Emerg Microbes Infect. 2020 Jun 12. PubMed PMID: 32529906

• Christian Bundschuh et al.
  Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma

      Clin Chim Acta. 2020 Oct. PubMed PMID: 32526218

• Xin Xu et al.
  Seroprevalence of Immunoglobulin M and G Antibodies Against SARS-CoV-2 in China

      Nat Med. 2020 Jun 5. PubMed PMID: 32504052​​​

• Florian Krammer et al.
  Serology assays to manage COVID-19

      Science. 2020 Jun 5. PubMed PMID: 32414781​

• Huan Ma et al.
  Serum IgA, IgM, and IgG responses in COVID-19

      Cell Mol Immunol. 2020 May 28. PubMed PMID: 32467617​

• Nadin Younes et al.
  Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2

      Viruses. 2020 May 26. PubMed PMID: 32466458

• Wanbing Liu et al.
  Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies Against SARS-CoV-2

      J Clin Microbiol . 2020 May 26. PubMed PMID: 32229605​

• Ling Zhong et al.
  Detection of serum IgM and IgG for COVID-19 diagnosis

      Sci China Life Sci. 2020 May. PubMed PMID: 32270436

• Fatima Amanat et al.
  A Serological Assay to Detect SARS-CoV-2 Seroconversion in Humans
  Nat Med. 2020 May 12. PubMed PMID: 32511441

• Nandini Sethuraman et al.
  Interpreting Diagnostic Tests for SARS-CoV-2
  JAMA. 2020;323(22):2249-2251. PubMed PMID: 32374370

• Libo Zhang et al.
  Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19
  Aging (Albany NY). 2020 Apr 30. PubMed PMID: 32320384

• Hongzhou Lu et al.
  An Evolving Approach to the Laboratory Assessment of COVID-19
  J Med Virol . 2020 Apr 29. PubMed PMID: 32347966

• Sarah Ee Fang Yong et al.
  Connecting clusters of COVID-19: an epidemiological and serological investigation
  Lancet Infect Dis. 2020 Apr 21. PubMed PMID: 32330439

• Fei Xiang et al.
  Antibody Detection and Dynamic Characteristics in Patients With COVID-19
  Clin Infect Dis. 2020 Apr 19. PubMed PMID: 32306047

• Juanjuan Zhao et al.
  Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019
  Cin Infect Dis. 2020 Mar 28. PubMed PMID: 32221519

• Li Guo et al.
  Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
  Clin Infect Dis. 2020 Mar 21. PubMed PMID: 32198501

​

​

参考文献

1.)平松　啓一, 標準微生物学, 第 11 版, 医学書院 (2012)

2.)Anu Haveri , “Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland,” January to February 2020 , Eurosurveillance.  Volume 25, Issue 11, 19, Mar 2020.

3.)Wanbing Liu, “Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2”, J Clin Microbiol. 2020 Mar 30.

4.)Li Guo, “Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)”, Clin Infect Dis. 2020 Mar 21.

5.)Juanjuan Zhao, “Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019”, Clin Infect Dis. 2020 Mar 21.

​

​